封面
市场调查报告书
商品编码
1972947

零售药局市场:市场洞察、竞争格局及市场预测(2033年)

Retail Pharmacy Market Insights, Competitive Landscape, and Market Forecast - 2033

出版日期: | 出版商: Fairfield Market Research | 英文 196 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球零售药局市场正经历重大变革,其驱动力包括不断增强的健康意识、慢性病盛行率的上升以及自我保健习惯的普及。预测显示,2026年市场规模将达到 6.868亿美元,到2033年将成长至 11.282亿美元,预测期内年复合成长率(CAGR)为 6.7%。这项成长凸显了零售药局在连结医疗服务与病患、提供便利的基本药物、保健品及相关医疗服务方面所扮演的关键角色。

市场概览

零售药房的业务范围已远远超出传统的处方配药。现代药局提供各式各样的产品,包括非处方药(OTC)、保健品、诊断工具和健康促进方案。此外,它们还提供病患教育和专业咨询服务,提升了消费者的信任度和参与度。自动化配药系统、行动应用程式和线上药局平台等技术的整合提高效率并提升客户体验。

对零售药局服务日益成长的需求与人口结构变化密切相关,尤其是在已开发地区人口老化和新兴经济体医疗保健成本上升方面。糖尿病、心血管疾病和高血压等慢性病盛行率的上升推动对药物和健康管理解决方案的持续需求。此外,政府支持政策,例如促进医疗保健服务可及性、扩大保险覆盖范围和增加仿製药供应,也对市场扩张产生了积极影响。

主要市场驱动因子

以下因素推动零售药局市场的成长:

  • 1.慢性病负担加重:长期疾病的盛行率导致人们对定期取得处方药和保健品的需求持续成长。零售药房在高效满足这一需求方面发挥核心作用。
  • 2.仿製药和非处方药的成长:仿製药的普及为品牌药提供了一种经济实惠的替代方案,使其价格更加亲民。非处方药则方便消费者应对轻微的健康问题。
  • 3.科技创新:线上药局平台、行动医疗应用和数位处方管理工具提升病患的就医便利性、便利性和安全性。
  • 4.政府支持和医疗保健政策:激励措施、偿付机制以及对药房基础设施建设的支持,促进服务范围的扩大和品质的提升。
  • 5.消费者对便利性的偏好:现代消费者更倾向于一站式零售药局模式,他们可以在这里一站式获得处方药、保健品和健康解决方案。

新的商机

零售药局市场为业务成长和创新提供了多种途径:

  • 数位化与全通路拓展:整合线上线下服务、送货上门和远距医疗解决方案,可扩大客户群,提升客户参与度。
  • 个人化健康服务:提供专业的健康检查、疫苗接种计画和用药指导,可以提供超越传统零售服务的附加价值。
  • 拓展新兴市场:亚太地区、拉丁美洲和中东地区由于医疗基础设施的不断完善和可支配收入的增加,具有巨大的成长潜力。
  • 自有品牌健康产品:开发自有品牌的维生素、补充剂和健康产品,可以强化品牌形象,并实现收入来源多元化。

区域展望

  • 北美:凭藉成熟的连锁药局、高额的医疗保健支出以及数位化药局解决方案的广泛应用,该地区保持领先地位。尤其是在美国,连锁药局和电子商务平台正推动着强劲的成长。
  • 欧洲:强大的医疗保健基础设施、完善的偿付系统和慢性病管理政策支撑着欧洲的成长。德国、法国和英国等国家已建立了完善的药局网路。
  • 亚太地区:快速的城市化进程、不断提高的健康意识以及政府推行的目的是促进民众获得可负担药品的计划,推动中国、印度和日本等国家的成长。
  • 拉丁美洲:零售网路的扩张和高性价比仿製药的普及推动了市场发展,其中巴西和墨西哥引领着成长。
  • 中东和非洲:儘管该地区仍在发展中,但由于医疗保健投资的增加、供应链的改善以及消费者健康意识的提高,该地区正经历着稳步成长。

主要参与者

零售药局市场竞争激烈,多家全球性公司利用其广泛的零售网路、数位平台和加值服务:

  • Walgreens Boots Alliance Inc.
  • CVS Health Corporation
  • Rite Aid Corporation
  • Walmart Inc.
  • Wal-Mart de Mexico, S.A.B. de C.V.
  • Costco Wholesale Corporation
  • Kroger Co.
  • McKesson Corporation
  • Cardinal Health Inc.
  • AmerisourceBergen Corporation
  • Albertsons Companies
  • Dirk Rossmann GmbH
  • The Jean Coutu Group (PJC) Inc.
  • Loblaws Inc.
  • Ahold Delhaize

这些公司持续寻求策略性收购、合作和技术创新,以巩固其市场地位、扩大地域覆盖范围并提升服务水准。

市场区隔

依类型

  • 仿製药
  • 非处方药(OTC)
  • 专利药或品牌药

依应用

  • 药品零售
  • 保健品零售
  • 医疗器材零售

依应用

  • 消费者/患者
  • 医疗机构
  • 传统医疗保健专业人员

依销售管道

  • 线上
  • 线下

依地区

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东及非洲

目录

第1章 执行摘要

第2章 市场概览

  • 市场定义与细分
  • 市场动态
    • 驱动因素
    • 限制因素
    • 市场机会
  • 价值链分析
  • 新冠疫情影响分析
  • 波特五力分析
  • 俄乌衝突的影响
  • PESTLE分析
  • 监理分析
  • 价格趋势分析
    • 当前价格及未来预测(2025-2033年)
    • 价格影响因素

第3章 全球零售2020-2033年全球药局市场展望

  • 全球零售药局市场展望,依类型,价值(十亿美元),2020-2033年
    • 仿製药
    • 非处方药(OTC)
    • 专利药或品牌药
  • 全球零售药局市场展望,依应用,价值(十亿美元),2020-2033年
    • 药品零售
    • 保健食品零售
    • 设备零售
  • 全球零售药局市场展望,依最终用途,价值(十亿美元),2020-2033年
    • 消费者/患者
    • 医疗机构
    • 传统医学从业人员
  • 全球零售药局市场展望,依通路,价值(十亿美元),2020–2033年
    • 线上
    • 线下
  • 全球零售药局市场展望,依地区,价值(十亿美元),2020–2033年
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第4章 北美零售药局市场展望,2020–2033年

第5章 欧洲零售药局市场展望,2020–2033年

第6章 亚太地区零售药局市场展望,2020–2033年

第7章 拉丁美洲零售药局市场展望,2020–2033

第8章 中东与非洲零售药局市场展望,2020–2033

第9章 竞争格局

  • 公司与细分市场热图
  • 公司市场占有率分析,2025年
  • 竞争格局概览
  • 公司简介
    • Walgreens Boots Alliance Inc.
    • CVS Health Corporation
    • Rite Aid Corporation
    • Walmart Inc.
    • Costco Wholesale Corporation
    • Kroger Co.
    • McKesson Corporation
    • Cardinal Health Inc.
    • AmerisourceBergen Corporation
    • Albertsons Companies

第10章 附录

简介目录

The global retail pharmacy market is undergoing significant transformation, fueled by rising healthcare awareness, increasing prevalence of chronic diseases, and the growing adoption of self-medication practices. Forecasts indicate that the market is expected to reach $686.8 million in 2026, expanding to $1,128.2 million by 2033, reflecting a CAGR of 6.7% over the forecast period. This growth underscores the crucial role that retail pharmacies play in connecting healthcare services with patients, providing easy access to essential medications, wellness products, and related healthcare services.

Market Overview

The retail pharmacy landscape has expanded well beyond conventional prescription dispensing. Today's pharmacies offer a wide array of products, including over-the-counter (OTC) medications, health supplements, diagnostic tools, and wellness solutions. They also provide patient education and professional consultation services, contributing to stronger consumer trust and engagement. Technological integration, such as automated dispensing systems, mobile applications, and online pharmacy platforms, is enhancing efficiency and improving the customer experience.

The growing demand for retail pharmacy services is closely tied to demographic shifts, particularly aging populations in developed regions and increasing healthcare expenditure in emerging economies. The rising prevalence of chronic illnesses like diabetes, cardiovascular conditions, and hypertension is driving consistent demand for medications and health management solutions. Additionally, supportive government policies promoting healthcare accessibility, insurance coverage, and generic medication adoption are positively impacting market expansion.

Key Market Drivers

Several factors are propelling the growth of the retail pharmacy market:

  • 1. Increasing Chronic Disease Burden: The prevalence of long-term conditions has created sustained demand for regular access to prescription medications and wellness products. Retail pharmacies are central to meeting this demand efficiently.
  • 2. Growth of Generic and OTC Medications: The adoption of generic drugs provides cost-effective alternatives to branded medications, increasing affordability. OTC medications allow consumers to manage minor health concerns conveniently.
  • 3. Technological Advancements: Online pharmacy platforms, mobile health apps, and digital prescription management tools are improving patient access, convenience, and safety.
  • 4. Government Support and Healthcare Policies: Incentives, reimbursement schemes, and support for pharmacy infrastructure development are enabling wider reach and better service delivery.
  • 5. Consumer Preference for Convenience: Modern consumers prefer the one-stop-shop model offered by retail pharmacies, which combines prescriptions, health products, and wellness solutions in a single location.

Emerging Business Opportunities

The retail pharmacy market presents several avenues for business growth and innovation:

  • Digital and Omnichannel Expansion: Integrating online and offline services, home delivery, and telemedicine solutions helps companies reach a broader customer base and improve engagement.
  • Personalized Health Services: Offering specialized health checks, vaccination programs, and medication counseling can provide added value beyond traditional retail offerings.
  • Market Penetration in Emerging Regions: Asia Pacific, Latin America, and the Middle East present high growth potential due to rising healthcare infrastructure and increasing disposable incomes.
  • Private Label and Branded Health Products: Developing proprietary vitamins, supplements, and wellness products can strengthen brand identity and diversify revenue streams.

Regional Outlook

  • North America: The region maintains a leading position, driven by mature pharmacy chains, high healthcare expenditure, and widespread adoption of digital pharmacy solutions. The United States, in particular, shows robust growth due to chain pharmacies and e-commerce platforms.
  • Europe: Growth in Europe is supported by strong healthcare infrastructure, reimbursement programs, and chronic disease management initiatives. Countries such as Germany, France, and the UK host well-established pharmacy networks.
  • Asia Pacific: Rapid urbanization, increasing healthcare awareness, and government programs promoting affordable medicine access are fueling growth in countries like China, India, and Japan.
  • Latin America: Expansion of retail networks and adoption of cost-effective generic medications drive market development, with Brazil and Mexico leading the growth trajectory.
  • Middle East & Africa: Although still emerging, this region is experiencing steady growth due to increasing healthcare investments, improving supply chains, and rising consumer health consciousness.

Leading Players

The retail pharmacy market is highly competitive, with several global players leveraging extensive retail networks, digital platforms, and value-added services:

  • Walgreens Boots Alliance Inc.
  • CVS Health Corporation
  • Rite Aid Corporation
  • Walmart Inc.
  • Wal-Mart de Mexico, S.A.B. de C.V.
  • Costco Wholesale Corporation
  • Kroger Co.
  • McKesson Corporation
  • Cardinal Health Inc.
  • AmerisourceBergen Corporation
  • Albertsons Companies
  • Dirk Rossmann GmbH
  • The Jean Coutu Group (PJC) Inc.
  • Loblaws Inc.
  • Ahold Delhaize

These companies continue to pursue strategic acquisitions, partnerships, and technological innovations to strengthen market position, expand geographic reach, and enhance service offerings.

Market Segmentation

By Type

  • Generic Medications
  • Over the Counter (OTC) Medications
  • Patented or Brand-name Medications

By Application

  • Drug Retail
  • Health Products Retail
  • Equipment Retail

By End Use

  • Consumer/Patients
  • Healthcare Facilities
  • Traditional Medicine Practitioners

By Channel

  • Online
  • Offline

By Geographic Coverage

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Retail Pharmacy Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Retail Pharmacy Market Outlook, 2020-2033

  • 3.1. Global Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 3.1.1. Generic Medications
    • 3.1.2. Over the Counter (OTC) Medications
    • 3.1.3. Patented or Brand-name Medications
  • 3.2. Global Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Drug Retail
    • 3.2.2. Health Products Retail
    • 3.2.3. Equipment Retail
  • 3.3. Global Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
    • 3.3.1. Consumer/Patients
    • 3.3.2. Healthcare Facilities
    • 3.3.3. Traditional Medicine Practitioners
  • 3.4. Global Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
    • 3.4.1. Online
    • 3.4.2. Offline
  • 3.5. Global Retail Pharmacy Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Retail Pharmacy Market Outlook, 2020-2033

  • 4.1. North America Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 4.1.1. Generic Medications
    • 4.1.2. Over the Counter (OTC) Medications
    • 4.1.3. Patented or Brand-name Medications
  • 4.2. North America Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Drug Retail
    • 4.2.2. Health Products Retail
    • 4.2.3. Equipment Retail
  • 4.3. North America Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
    • 4.3.1. Consumer/Patients
    • 4.3.2. Healthcare Facilities
    • 4.3.3. Traditional Medicine Practitioners
  • 4.4. North America Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
    • 4.4.1. Online
    • 4.4.2. Offline
  • 4.5. North America Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 4.5.2. U.S. Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 4.5.3. U.S. Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 4.5.4. U.S. Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 4.5.5. Canada Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 4.5.6. Canada Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 4.5.7. Canada Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 4.5.8. Canada Retail Pharmacy Market Outlook, by Channel, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Retail Pharmacy Market Outlook, 2020-2033

  • 5.1. Europe Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 5.1.1. Generic Medications
    • 5.1.2. Over the Counter (OTC) Medications
    • 5.1.3. Patented or Brand-name Medications
  • 5.2. Europe Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Drug Retail
    • 5.2.2. Health Products Retail
    • 5.2.3. Equipment Retail
  • 5.3. Europe Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
    • 5.3.1. Consumer/Patients
    • 5.3.2. Healthcare Facilities
    • 5.3.3. Traditional Medicine Practitioners
  • 5.4. Europe Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
    • 5.4.1. Online
    • 5.4.2. Offline
  • 5.5. Europe Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.2. Germany Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.3. Germany Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.4. Germany Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 5.5.5. Italy Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.6. Italy Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.7. Italy Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.8. Italy Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 5.5.9. France Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.10. France Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.11. France Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.12. France Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 5.5.13. U.K. Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.14. U.K. Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.15. U.K. Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.16. U.K. Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 5.5.17. Spain Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.18. Spain Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.19. Spain Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.20. Spain Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 5.5.21. Russia Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.22. Russia Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.23. Russia Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.24. Russia Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 5.5.25. Rest of Europe Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 5.5.26. Rest of Europe Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 5.5.27. Rest of Europe Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 5.5.28. Rest of Europe Retail Pharmacy Market Outlook, by Channel, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Retail Pharmacy Market Outlook, 2020-2033

  • 6.1. Asia Pacific Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 6.1.1. Generic Medications
    • 6.1.2. Over the Counter (OTC) Medications
    • 6.1.3. Patented or Brand-name Medications
  • 6.2. Asia Pacific Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Drug Retail
    • 6.2.2. Health Products Retail
    • 6.2.3. Equipment Retail
  • 6.3. Asia Pacific Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
    • 6.3.1. Consumer/Patients
    • 6.3.2. Healthcare Facilities
    • 6.3.3. Traditional Medicine Practitioners
  • 6.4. Asia Pacific Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
    • 6.4.1. Online
    • 6.4.2. Offline
  • 6.5. Asia Pacific Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 6.5.2. China Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 6.5.3. China Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 6.5.4. China Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 6.5.5. Japan Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 6.5.6. Japan Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 6.5.7. Japan Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 6.5.8. Japan Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 6.5.9. South Korea Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 6.5.10. South Korea Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 6.5.11. South Korea Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 6.5.12. South Korea Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 6.5.13. India Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 6.5.14. India Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 6.5.15. India Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 6.5.16. India Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 6.5.17. Southeast Asia Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 6.5.18. Southeast Asia Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 6.5.19. Southeast Asia Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 6.5.20. Southeast Asia Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 6.5.21. Rest of SAO Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 6.5.22. Rest of SAO Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 6.5.23. Rest of SAO Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 6.5.24. Rest of SAO Retail Pharmacy Market Outlook, by Channel, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Retail Pharmacy Market Outlook, 2020-2033

  • 7.1. Latin America Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 7.1.1. Generic Medications
    • 7.1.2. Over the Counter (OTC) Medications
    • 7.1.3. Patented or Brand-name Medications
  • 7.2. Latin America Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Drug Retail
    • 7.2.2. Health Products Retail
    • 7.2.3. Equipment Retail
  • 7.3. Latin America Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
    • 7.3.1. Consumer/Patients
    • 7.3.2. Healthcare Facilities
    • 7.3.3. Traditional Medicine Practitioners
  • 7.4. Latin America Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
    • 7.4.1. Online
    • 7.4.2. Offline
  • 7.5. Latin America Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 7.5.2. Brazil Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 7.5.3. Brazil Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 7.5.4. Brazil Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 7.5.5. Mexico Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 7.5.6. Mexico Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 7.5.7. Mexico Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 7.5.8. Mexico Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 7.5.9. Argentina Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 7.5.10. Argentina Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 7.5.11. Argentina Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 7.5.12. Argentina Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 7.5.13. Rest of LATAM Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 7.5.14. Rest of LATAM Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 7.5.15. Rest of LATAM Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 7.5.16. Rest of LATAM Retail Pharmacy Market Outlook, by Channel, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Retail Pharmacy Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Retail Pharmacy Market Outlook, by Type, Value (US$ Bn), 2020-2033
    • 8.1.1. Generic Medications
    • 8.1.2. Over the Counter (OTC) Medications
    • 8.1.3. Patented or Brand-name Medications
  • 8.2. Middle East & Africa Retail Pharmacy Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Drug Retail
    • 8.2.2. Health Products Retail
    • 8.2.3. Equipment Retail
  • 8.3. Middle East & Africa Retail Pharmacy Market Outlook, by End Use, Value (US$ Bn), 2020-2033
    • 8.3.1. Consumer/Patients
    • 8.3.2. Healthcare Facilities
    • 8.3.3. Traditional Medicine Practitioners
  • 8.4. Middle East & Africa Retail Pharmacy Market Outlook, by Channel, Value (US$ Bn), 2020-2033
    • 8.4.1. Online
    • 8.4.2. Offline
  • 8.5. Middle East & Africa Retail Pharmacy Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 8.5.2. GCC Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 8.5.3. GCC Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 8.5.4. GCC Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 8.5.5. South Africa Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 8.5.6. South Africa Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 8.5.7. South Africa Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 8.5.8. South Africa Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 8.5.9. Egypt Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 8.5.10. Egypt Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 8.5.11. Egypt Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 8.5.12. Egypt Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 8.5.13. Nigeria Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 8.5.14. Nigeria Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 8.5.15. Nigeria Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 8.5.16. Nigeria Retail Pharmacy Market Outlook, by Channel, 2020-2033
    • 8.5.17. Rest of Middle East Retail Pharmacy Market Outlook, by Type, 2020-2033
    • 8.5.18. Rest of Middle East Retail Pharmacy Market Outlook, by Application, 2020-2033
    • 8.5.19. Rest of Middle East Retail Pharmacy Market Outlook, by End Use, 2020-2033
    • 8.5.20. Rest of Middle East Retail Pharmacy Market Outlook, by Channel, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Walgreens Boots Alliance Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. CVS Health Corporation
    • 9.4.3. Rite Aid Corporation
    • 9.4.4. Walmart Inc.
    • 9.4.5. Costco Wholesale Corporation
    • 9.4.6. Kroger Co.
    • 9.4.7. McKesson Corporation
    • 9.4.8. Cardinal Health Inc.
    • 9.4.9. AmerisourceBergen Corporation
    • 9.4.10. Albertsons Companies

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations